Substituent effects on P2-cyclopentyltetrahydrofuranyl urethanes: Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors

被引：18

作者：

Ghosh, Arun K. ^{[1
,2
]}

Chapsal, Bruno D. ^{[1
,2
]}

Steffey, Melinda ^{[1
,2
]}

Agniswamy, Johnson ^{[3
]}

Wang, Yuan-Fang ^{[3
]}

Amano, Masayuki ^{[4
,5
]}

Weber, Irene T. ^{[3
]}

Mitsuya, Hiroaki ^{[4
,5
,6
]}

机构：

[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA

[2] Purdue Univ, Dept Med Chem, W Lafayette, IN 47907 USA

[3] Georgia State Univ, Dept Biol, Atlanta, GA 30303 USA

[4] Kumamoto Univ, Dept Hematol, Grad Sch Med & Pharmaceut Sci, Kumamoto 8608556, Japan

[5] Kumamoto Univ, Dept Infect Dis, Grad Sch Med & Pharmaceut Sci, Kumamoto 8608556, Japan

[6] NCI, Expt Retrovirol Sect, HIV & AIDS Malignancy Branch, NIH, Bethesda, MD 20892 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2012年 / 22卷 / 06期

基金：

美国国家卫生研究院;

关键词：

HIV-1 protease inhibitors; P2; ligand; Drug resistance; Design and synthesis; X-ray crystal structure; DRUG-RESISTANT MUTANTS; BIOLOGICAL EVALUATION; P2-LIGANDS; BACKBONE;

D O I：

10.1016/j.bmcl.2012.01.061

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The design, synthesis, and biological evaluation of novel C3-substituted cyclopentyltetrahydrofuranyl (Cp-THF)-derived HIV-1 protease inhibitors are described. Various C3-functional groups on the Cp-THF ligand were investigated in order to maximize the ligand-binding site interactions in the flap region of the protease. Inhibitors 3c and 3d have displayed the most potent enzyme inhibitory and antiviral activity. Both inhibitors have maintained impressive activity against a panel of multidrug resistant HIV-1 variants. A high-resolution X-ray crystal structure of 3c-bound HIV-1 protease revealed a number of important molecular insights into the ligand-binding site interactions. (C) 2012 Elsevier Ltd. All rights reserved.

引用

页码：2308 / 2311

页数：4

共 50 条

[1] Design, synthesis, and X-ray studies of potent HIV-1 protease inhibitors incorporating aminothiochromane and aminotetrahydronaphthalene carboxamide derivatives as the P2 ligands
Ghosh, Arun K.
Jadhav, Ravindra D.
Simpson, Hannah
Kovela, Satish
Osswald, Heather
Agniswamy, Johnson
Wang, Yuan-Fang
Hattori, Shin-ichiro
Weber, Irene T.
Mitsuya, Hiroaki
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 160 : 171 - 182
[2] Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide Functionalities
Ghosh, Arun K.
Grillo, Alessandro
Raghavaiah, Jakka
Kovela, Satish
Johnson, Megan E.
Kneller, Daniel W.
Wang, Yuan-Fang
Hattori, Shin-ichiro
Higashi-Kuwata, Nobuyo
Weber, Irene T.
Mitsuya, Hiroaki
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1965 - 1972
[3] Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2 Ligands of Darunavir
Ghosh, Arun K.
Fyvie, W. Sean
Brindisi, Margherita
Steffey, Melinda
Agniswamy, Johnson
Wang, Yuan-Fang
Aoki, Manabu
Amano, Masayuki
Weber, Irene T.
Mitsuya, Hiroaki
CHEMMEDCHEM, 2017, 12 (23) : 1942 - 1952
[4] Highly Potent HIV-1 Protease Inhibitors with Novel Tricyclic P2 Ligands: Design, Synthesis, and Protein-Ligand X-ray Studies
Ghosh, Arun K.
Parham, Garth L.
Martyr, Cuthbert D.
Nyalapatla, Prasanth R.
Osswald, Heather L.
Agniswamy, Johnson
Wang, Yuan-Fang
Amano, Masayuki
Weber, Irene T.
Mitsuya, Hiroaki
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (17) : 6792 - 6802
[5] Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1′-P2′ ligands
Ghosh, Arun K.
Fyvie, W. Sean
Brindisi, Margherita
Steffey, Melinda
Agniswamy, Johnson
Wang, Yuan-Fang
Aoki, Manabu
Amano, Masayuki
Weber, Irene T.
Mitsuya, Hiroaki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (21) : 4925 - 4931
[6] Design and Synthesis of Potent HIV-1 Protease Inhibitors Containing Bicyclic Oxazolidinone Scaffold as the P2 Ligands: Structure-Activity Studies and Biological and X-ray Structural Studies
Ghosh, Arun K.
Williams, Jacqueline N.
Ho, Rachel Y.
Simpson, Hannah M.
Hattori, Shin-ichiro
Hayashi, Hironori
Agniswamy, Johnson
Wang, Yuan-Fang
Weber, Irene T.
Mitsuya, Hiroaki
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (21) : 9722 - 9737
[7] Potent HIV-1 protease inhibitors containing oxabicyclo octanol-derived P2-ligands: Design, synthesis, and X-ray structural studies of inhibitor-HIV-1 protease complexes
Ghosh, Arun K.
Yadav, Monika
Sharma, Ashish
Johnson, Megan
Ghosh, Ajay K.
Prasad, Rangu
Amano, Masayuki
Gerlits, Oksana
Kovalevsky, Andrey
Mitsuya, Hiroaki
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2025, 120
[8] Design and synthesis of potent HIV-1 protease inhibitors incorporating hydroxyprolinamides as novel P2 ligands
Gao, Bing-Lei
Zhang, Cheng-Mei
Yin, Yi-Zhen
Tang, Long-Qian
Liu, Zhao-Peng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (12) : 3730 - 3733
[9] Design and synthesis of highly potent HIV-1 protease inhibitors with novel isosorbide-derived P2 ligands
Qiu, Xin
Zhao, Guo-Dong
Tang, Long-Qiang
Liu, Zhao-Peng
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (11) : 2465 - 2468
[10] Design of HIV-1 Protease Inhibitors with C3-Substituted Hexahydrocyclopentafuranyl Urethanes as P2-Ligands: Synthesis, Biological Evaluation, and Protein-Ligand X-ray Crystal Structure
Ghosh, Arun K.
Chapsal, Bruno D.
Parham, Garth L.
Steffey, Melinda
Agniswamy, Johnson
Wang, Yuan-Fang
Amano, Masayuki
Weber, Irene T.
Mitsuya, Hiroaki
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (16) : 5890 - 5901

← 1 2 3 4 5 →